DermTech (DMTK) Misses Q1 EPS by 11c

DermTech (NASDAQ: DMTK) reported Q1 EPS of ($1.02), $0.11 worse than the analyst estimate of ($0.91). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $3.5 million.

For earnings history and earnings-related data on DermTech (DMTK) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Occidental Petroleum releases Q2 2026 earnings considerations
• Delta Air shares slip despite strong outlook, Melius says